We believe that a functional interaction between MTA1 and these two downstream pathways is critical for the acquisition of an invasive phenotype by tumor cells, offering new therapeutic approaches for targeting MTA1‐positive high‐risk tumors to prevent metastases. The gene discussed is MTA1; the disease is neoplasm.